NAFLD, NASH & Living Donor Liver Transplantation

Event Information

Share this event

Date and Time

Event description
Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH) & Living Liver Donor Transplantation

About this Event

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease in Canada, affecting approximately 20 per cent of Canadians. Non-Alcoholic Steatohepatitis (NASH), is a severe type of NAFLD. NASH may lead to serious scarring of the liver (cirrhosis), liver cancer, and end-stage liver failure.

For individuals experiencing end-stage liver failure, living liver donor transplantation may provide a shorter pathway to better health, better long-term outcomes, and the benefit of a planned surgery.

Join us for an online presentation about NAFLD, NASH & Living Liver Donor Transplantation presented by Dr. Nazia Selzner, medical director of the living liver donor program, UHN.

Learn more about NAFLD and NASH



Share with friends

Date and Time


Online Event

Save This Event

Event Saved